Biotechnology Assets, S.A.

€0.20As of Sun 8 Nov 2026, 12:00 UTC
BME:BSTHealthcare
Country Spain
PE (Fwd) •••
TSR 8Y CAGR (25.23%)
Div yield —
ROE (35.89%)
Biotechnology
Beta (5Y) 2.11
PE TTM —
TSR TTM (40.88%)
Mkt cap €15.09M
ROIC (20.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.26
29.37%
(45.42%)
Hold 2|6|1|7|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
—
—
—
—
11.38%
3.89%
7.30%
8.84%
Revenue€M
1.307
1.349
1.385
1.405
0.08%
5.28%
8.94%
8.46%
Peers (US$16.94M)
Cap (US$)
PE
225.9M
—
115.7M
25.56x
Capital
TTM
5Y
10Y
Leveragex
2.251
0.117
0.114
EBIT/Intx
0.655
0.951
0.716
Own earn%
(20.61)
(182.25)
(148.01)
Sh yield%
41.39
37.54
33.11
Owners
Insiders/Inst%
9.01
61.58
Short interest%
1.76
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
1–13
$1 testx
0.0
Incr. ROIC%
5